These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37748702)

  • 1. Harmonisation of read-across methodology for drug substance extractables and leachables (E&Ls).
    Masuda-Herrera M; Rosen HT; Burild A; Broschard T; Bell T; Graham J; Griffin T; Hillegass J; Leavitt P; Huta B; Parris P; Bruen U; Cruz M; Bercu J
    Regul Toxicol Pharmacol; 2023 Dec; 145():105494. PubMed ID: 37748702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creating a Holistic Extractables and Leachables (E&L) Program for Biotechnology Products.
    Li K; Rogers G; Nashed-Samuel Y; Lee H; Mire-Sluis A; Cherney B; Forster R; Yeh P; Markovic I
    PDA J Pharm Sci Technol; 2015; 69(5):590-619. PubMed ID: 26429108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A compilation of safety impact information for extractables associated with materials used in pharmaceutical packaging, delivery, administration, and manufacturing systems.
    Jenke D; Carlson T
    PDA J Pharm Sci Technol; 2014; 68(5):407-55. PubMed ID: 25336416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on the PQRI Extractables and Leachables "Safety Thresholds and Best Practices" Recommendations for Inhalation Drug Products.
    Norwood DL; Nagao LM; Stults CL
    PDA J Pharm Sci Technol; 2013; 67(5):413-29. PubMed ID: 24084658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations when deriving compound-specific limits for extractables and leachables from pharmaceutical products: Four case studies.
    Parris P; Martin EA; Stanard B; Glowienke S; Dolan DG; Li K; Binazon O; Giddings A; Whelan G; Masuda-Herrera M; Bercu J; Broschard T; Bruen U; Callis CM; Stults CLM; Erexson GL; Cruz MT; Nagao LM
    Regul Toxicol Pharmacol; 2020 Dec; 118():104802. PubMed ID: 33038429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Product Quality Research Institute (PQRI) Leachables and Extractables Working Group Initiatives for Parenteral and Ophthalmic Drug Product (PODP).
    Paskiet D; Jenke D; Ball D; Houston C; Norwood DL; Markovic I
    PDA J Pharm Sci Technol; 2013; 67(5):430-47. PubMed ID: 24084659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Principles for Management of Extractables and Leachables in Ophthalmic Drug Products.
    Houston CT; Rodrigues AD; Smith BB; Wang T; Richardson M
    PDA J Pharm Sci Technol; 2022; 76(3):278-294. PubMed ID: 35169039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Framework for sensitization assessment of extractables and leachables in pharmaceuticals.
    Parris P; Whelan G; Burild A; Whritenour J; Bruen U; Bercu J; Callis C; Graham J; Johann E; Griffin T; Kohan M; Martin EA; Masuda-Herrera M; Stanard B; Tien E; Cruz M; Nagao L
    Crit Rev Toxicol; 2022 Feb; 52(2):125-138. PubMed ID: 35703156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardization of Chromatographic Screening Methods for Organic Extractables and Leachables by Managing Outcomes.
    Jenke D
    PDA J Pharm Sci Technol; 2023; 77(4):329-338. PubMed ID: 37001885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Duration-Based Non-Mutagenic Thresholds of Toxicological Concern (TTCs) Relevant to Parenteral Extractables and Leachables (E&Ls).
    Masuda-Herrera MJ; Bercu JP; Broschard TH; Burild A; Hasselgren C; Parris P; Ford LC; Graham J; Stanard B; Comerford M; Lettiere D; Erler S; Callis CM; Morinello E; Muster W; Martin EA; Griffin TR; Nagao L; Cruz M
    PDA J Pharm Sci Technol; 2022; 76(5):369-383. PubMed ID: 35031541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extractables and leachables considerations for prefilled syringes.
    Jenke DR
    Expert Opin Drug Deliv; 2014 Oct; 11(10):1591-600. PubMed ID: 24955780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of mass spectrometry and related techniques in the analysis of extractable and leachable chemicals.
    Sica VP; Krivos KL; Kiehl DE; Pulliam CJ; Henry ID; Baker TR
    Mass Spectrom Rev; 2020 Mar; 39(1-2):212-226. PubMed ID: 30921495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking extractables and leachables in container/closure applications.
    Jenke DR
    PDA J Pharm Sci Technol; 2005; 59(4):265-81. PubMed ID: 16218205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing relative response factor variation using a multidetector approach for extractables and leachables (E&L) analysis to mitigate the need for uncertainty factors.
    Jordi MA; Rowland K; Liu W; Cao X; Zong J; Ren Y; Liang Z; Zhou X; Louis M; Lerner K
    J Pharm Biomed Anal; 2020 Jul; 186():113334. PubMed ID: 32387747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and quantification of extractables and leachables in laminated film and pouches for pharmaceutical packaging.
    Fu C; Zhang X; Lei S; Zou M; Wang L; Jiao J; Yang Q
    J Pharm Biomed Anal; 2022 Oct; 220():115015. PubMed ID: 36054946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing safety of extractables from materials and leachables in pharmaceuticals and biologics - Current challenges and approaches.
    Broschard TH; Glowienke S; Bruen US; Nagao LM; Teasdale A; Stults CL; Li KL; Iciek LA; Erexson G; Martin EA; Ball DJ
    Regul Toxicol Pharmacol; 2016 Nov; 81():201-211. PubMed ID: 27569203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Best practices for extractables and leachables in orally inhaled and nasal drug products: an overview of the PQRI recommendations.
    Norwood DL; Paskiet D; Ruberto M; Feinberg T; Schroeder A; Poochikian G; Wang Q; Deng TJ; DeGrazio F; Munos MK; Nagao LM
    Pharm Res; 2008 Apr; 25(4):727-39. PubMed ID: 18183477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the chemical compatibility of plastic contact materials and pharmaceutical products; safety considerations related to extractables and leachables.
    Jenke D
    J Pharm Sci; 2007 Oct; 96(10):2566-81. PubMed ID: 17701994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendation of Single Time Point Leachables Testing for Lyophilized Biotechnology Products Stored in Rubber Stoppered Glass Vial Systems.
    Gallegos A; Liu J; Ronk M; Qi L; Li K; Semin D; Nashed-Samuel Y
    J Pharm Sci; 2022 Jun; 111(6):1599-1604. PubMed ID: 35257694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulated Leaching (Migration) Study for a Model Container-Closure System Applicable to Parenteral and Ophthalmic Drug Products.
    Jenke D; Egert T; Hendricker A; Castner J; Feinberg T; Houston C; Hunt DG; Lynch M; Nicholas K; Norwood DL; Paskiet D; Ruberto M; Smith EJ; Holcomb F; Markovic I
    PDA J Pharm Sci Technol; 2017; 71(2):68-87. PubMed ID: 27974627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.